Altered Peripheral Immune Profiles in First-Episode, Drug-Free Patients With Schizophrenia: Response to Antipsychotic Medications
Previous research has demonstrated aberrations in the levels of inflammatory cytokines in patients with schizophrenia (SCZ), but most of the respective studies have tested a narrow set of inflammatory cytokines. Here, we aimed to analyze broad immune profiles in the peripheral blood of the first-epi...
Guardado en:
Autores principales: | Lei Chen, Wen-Hui Zheng, Yang Du, Xue-Song Li, Yun Yu, Hua Wang, Yong Cheng |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/3f7b67d32b6b492a871f13e3a66b0798 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Changes in Brain Structure, Function, and Network Properties in Patients With First-Episode Schizophrenia Treated With Antipsychotics
por: Ping Yin, et al.
Publicado: (2021) -
Gender Differences in the First-Year Antipsychotic Treatment for Chinese First-Episode Schizophrenia
por: Pu C, et al.
Publicado: (2020) -
Characterization of antipsychotic medications, amino acid signatures, and platelet-activating factor in first-episode psychosis
por: Bracha Erlanger Avigdor, et al.
Publicado: (2021) -
Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review
por: Karson C, et al.
Publicado: (2016) -
Aberrant Learned Irrelevance in Patients with First-Episode Schizophrenia-Spectrum Disorder
por: Ryan Sai-Ting Chu, et al.
Publicado: (2021)